跳至主要内容
临床试验/TCTR20150220001
TCTR20150220001招募中4 期

Dietary Phosphorus Control versus Combination of Diet and Calcium Carbonate as Phosphate Binder Therapy for Reduction of Serum Fibroblast Growth Factor 23 (FGF 23) in Chronic Kidney Disease Stage 3

Siriraj Research and Development Fund Type 20 个研究点目标入组 75 人开始时间: 2015年2月20日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Chronic kidney disease stage 3 defined by estimated GFR using CKD-EPI formula
  • Age >18 years old
  • FGF-23 > 100 RU/m

排除标准

  • 1. Serum albumin corrected calcium > 9.6 mg/dL or serum phosphate > 4.5 mg/dL or intact PTH > 65 pg/mL
  • 2. History of symptomatic hypocalcemia
  • 3. History of calculi in genitourinary system
  • 4. Primary hyperparathyroidism
  • 5. History of thyroidectomy, parathyroidectomy, or radiation of head and neck
  • 6. Patients prescribed drugs interfering vitamin D and/or bone metabolism, for example, corticosteroids, phenytoin, calcimimetics, calcineurin inhibitor, etc.
  • 6. Patients diagnosed osteoporosis and treated with bislphosphonates and/ or estrogen derivatives
  • 7. Pregnancy

研究者

发起方
Siriraj Research and Development Fund Type 2

相似试验